Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten L Simoons

Showing results (141-150 of 185) with videos related to

Pageof 19
Sort By:
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
European Heart Journal|November 10, 2006
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromesCynthia M Westerhout, Adrián V Hernández, Ewout W Steyerberg, et al.
American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.
Circulation|February 7, 2007
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Timo Peter, et al.
The American Journal of Medicine|June 24, 2004
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise testsArend F L Schinkel, Jeroen J Bax, Abdou Elhendy, et al.
American Heart Journal|April 13, 2004
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarctionArthur C P Maas, Christina M Wyatt, Cynthia L Green, et al.
Thrombosis and Haemostasis|June 10, 2011
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary interventionJanine E van Loon, Peter P T de Jaegere, Hans Ulrichts, et al.
Journal of the American College of Cardiology|January 5, 2005
Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosisElena Biagini, Abdou Elhendy, Jeroen J Bax, et al.
The American Journal of Cardiology|April 22, 2005
Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test resultsElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
The American Journal of Medicine|October 1, 2005
Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk indexEric Boersma, Miklos D Kertai, Olaf Schouten, et al.
Pageof 19

Showing results (141-150 of 185) with videos related to

Sort By:
Pageof 19
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
European Heart Journal|November 10, 2006
Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromesCynthia M Westerhout, Adrián V Hernández, Ewout W Steyerberg, et al.
American Heart Journal|January 7, 2003
Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trialsDavid Hasdai, Eric J Topol, Rakhi Kilaru, et al.
Circulation|February 7, 2007
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndromeKai C Wollert, Tibor Kempf, Timo Peter, et al.
The American Journal of Medicine|June 24, 2004
Long-term prognostic value of dobutamine stress echocardiography compared with myocardial perfusion scanning in patients unable to perform exercise testsArend F L Schinkel, Jeroen J Bax, Abdou Elhendy, et al.
American Heart Journal|April 13, 2004
Combining baseline clinical descriptors and real-time response to therapy: the incremental prognostic value of continuous ST-segment monitoring in acute myocardial infarctionArthur C P Maas, Christina M Wyatt, Cynthia L Green, et al.
Thrombosis and Haemostasis|June 10, 2011
The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary interventionJanine E van Loon, Peter P T de Jaegere, Hans Ulrichts, et al.
Journal of the American College of Cardiology|January 5, 2005
Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosisElena Biagini, Abdou Elhendy, Jeroen J Bax, et al.
The American Journal of Cardiology|April 22, 2005
Comparison of all-cause mortality in women with known or suspected coronary artery disease referred for dobutamine stress echocardiography with normal versus abnormal test resultsElena Biagini, Abdou Elhendy, Arend F L Schinkel, et al.
The American Journal of Medicine|October 1, 2005
Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk indexEric Boersma, Miklos D Kertai, Olaf Schouten, et al.
Pageof 19